First Lawsuit Filed Over Elmiron Eye Damage - Pelczar v. Teva Branded Pharmaceuticals R&D et al - Interstitial Cystitis Network
USFDA warns of Teva Pharma ADHD drug Adderall shortage
Teva's New CEO Francis Takes Over A Steadier – Though Still Rocky – Organization :: Scrip
Xylometazoline 1 mg spray Teva - 10 ml | Medische Vakhandel
Teva joins forces with Icelandic firm to gain edge on biosimilars | The Times of Israel
New CEO will lead Teva at top of new year—Chutes & Ladders
Cipla signs pact with Teva Pharmaceuticals for selling drugs in South Africa - The Economic Times
OPHTAL - ADC.sk
1757152 - Henry Schein Medical
Q&A: Electronic inhaler system helps patients improve asthma control
Teva launches generic version of Celebrex caps | Drug Store News
Teva refiles NDA for schizophrenia treatment
Transitioning Teva revamps branding to emphasize brand-generic unity | Fierce Pharma
5502943 - Henry Schein Medical
00093321915 - Henry Schein Medical
Teva Ophtal 4x25ml | Pricemania
UK First to Grant License for Teva | OBN
Global Ophthalmology Therapeutics Market 2023-2027
Teva Holds off Huntington's Competitor, Resolves Opioid Cases | BioSpace
Teva wins U.K. approval for Lucentis biosimilar (NYSE:TEVA) | Seeking Alpha
Teva's flagship drug Austedo scores new approval at the FDA
United Kingdom first to grant license for Teva's ophthalmology biosimilar Ongavia
OPHTAL - ADC.sk
Pharma has set its sights on ophthalmology opportunities
EpiPen litigation comes back to haunt Teva
